[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336032-105":59,"doc-detail-336032-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","development-and-clinical-validation-of-a-seven-gene-signature-based-on-tumor-stem-cell-related-genes-to-predict-ovarian-cancer-prognosis","Development and clinical validation of a seven-gene signature based on tumor stem cell-related genes to predict ovarian cancer prognosis","","Objective: Ovarian tumors show strong heterogeneity, and tumor-stem cells within the tumor microenvironment drive key behaviors including differentiation potential, high oncogenicity, self-renewal, chemotherapy resistance, and recurrence. Because ovarian cancer shares characteristics with tumor stem cells, molecular markers linked to these cells may help clarify prognosis-related biology. Methods: Stem cell-related genes were selected and molecular subtypes defined using TCGA expression data with ConsensusClusterPlus. Prognostic markers were built using LASSO regression, followed by gene set enrichment to explore mechanisms. Marker robustness was tested across cohorts, and clinical independence was assessed via multivariate Cox analysis; a nomogram was created. Immunohistochemistry validated hub gene expression. Results: Forty-nine prognostic tumor-stem-cell-related genes separated 362 samples into two clusters with distinct outcomes. A stable seven-gene signature (GALP, CACNA1C, COL16A1, PENK, C4BPA, PSMA2, CXCL9) remained robust across platforms and showed independent survival prediction in multivariate Cox models. The combined nomogram improved prognostic performance. IHC confirmed higher expression of all seven genes in cancer tissues. Conclusion: The seven-gene signature provides a promising decision-making and prognosis prediction tool for ovarian cancer.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-and-clinical-validation-of-a-seven-gene-signature-based-on-tumor-stem-cell-related-genes-to-predict-ovarian-cancer-prognosis/336032/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-and-clinical-validation-of-a-seven-gene-signature-based-on-tumor-stem-cell-related-genes-to-predict-ovarian-cancer-prognosis/336032.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of the study on ovarian cancer?","Question",{"text":112,"@type":113},"To develop and clinically validate a seven-gene signature derived from tumor stem cell-related genes that can predict ovarian cancer prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were molecular subtypes and prognostic markers identified?",{"text":117,"@type":113},"Molecular subtypes were formed from TCGA gene expression data using ConsensusClusterPlus. Prognostic markers were selected using LASSO regression, followed by gene set enrichment analysis to infer potential mechanisms.",{"name":119,"@type":110,"acceptedAnswer":120},"What genes are included in the final seven-gene signature and how was it validated?",{"text":121,"@type":113},"The signature includes GALP, CACNA1C, COL16A1, PENK, C4BPA, PSMA2, and CXCL9. Validation used robustness testing across cohorts, multivariate Cox analysis for clinical independence, nomogram assessment, and immunohistochemistry to confirm increased expression in cancer tissues.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336032,1790150819,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":4},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Wang et al. Journal of Ovarian Research (2024) 17:58  \n[https://doi.org/10.1186/s13048-023-01326-8](https://doi.org/10.1186/s13048-023-01326-8)  \nJournal of Ovarian Research  \n RESEARCH Open Access  \nDevelopment and clinical validation  \nof a seven-gene signature based on tumor stem cell-related genes to predict ovarian cancer prognosis  \nGuangwei Wang1, Xiaofei Liu2, Yue You1, Silei Chen1, Xiaohan Chang1 and Qing Yang1*  \nAbstract  \nObjective Tumors are highly heterogeneous, and within their parenchyma, a small population of tumor-stem cells possessing differentiation potential, high oncogenicity, and self-renewal capabilities exists. These cells are pivotal in mediating tumor development, chemotherapy resistance, and recurrence. Ovarian cancer shares characteristics with tumor stem cells, making it imperative to investigate molecular markers associated with these cells.  \nMethods Stem cell-related genes were collected, and molecular subtypes were established based on gene expression profiles from The Cancer Genome Atlas using the R package tool“ConsensusClusterPlus.” Multi-gene prognostic markers were identified using LASSO regression analysis. Gene set enrichment analysis was employed to gain insights into the potential molecular mechanisms of these identified markers. The robustness of these prognostic markers was analyzed across different cohorts, and their clinical independence was determined through multivariate Cox analysis. A nomogram was constructed to assess the model’s clinical applicability. Immunohistochemistry was performed to validate the expression of hub genes.  \nResults Utilizing 49 tumor stem cell-related genes associated with prognosis, 362 ovarian cancer samples were divided into two distinct clusters, revealing significant prognostic disparities. A seven-gene signature (GALP, CACNA1C, COL16A1, PENK, C4BPA, PSMA2, and CXCL9), identified through LASSO regression, exhibited stability and robustness across various platforms. Multivariate Cox regression analysis confirmed the signature’s independence in predicting survival in patients with ovarian cancer. Furthermore, a nomogram combining the gene signature demonstrated strong predictive abilities. Immunohistochemistry results indicated significantly elevated GALP, CACNA1C, COL16A1, PENK, C4BPA, PSMA2, and CXCL9 expression in cancer tissues.  \nConclusion The seven-gene signature holds promise as a valuable tool for decision-making and prognosis prediction in patients with ovarian cancer.  \nKeywords Tumor stem cell, Ovarian cancer, Marker, Prognosis  \n*Correspondence: Qing Yang [yangq@sj-hospital.org](yangq@sj-hospital.org)  \n1 Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China  \n2 Shenyang Women’s and Children’s Hospital, Shenyang, China  \nIntroduction  \nOvarian cancer is one of the most prevalent malignancies affecting the female reproductive system. In 2020, the United States anticipated 21,750 new cases of ovarian cancer and 13,940 ovarian cancer-related deaths [1]. Approximately 70% of patients with ovarian cancer are diagnosed at an advanced stage, primarily attributed to  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativ","cbCailxJDDJCiopu","https://ap.wps.com/l/cbCailxJDDJCiopu","pdf",16012265,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Ovarian cancer burden and prognosis\n## Tumor stem cells and biological roles\n## Need for tumor stem cell-related markers","[{\"question\":\"What is the main objective of the study on ovarian cancer?\",\"answer\":\"To develop and clinically validate a seven-gene signature derived from tumor stem cell-related genes that can predict ovarian cancer prognosis.\"},{\"question\":\"How were molecular subtypes and prognostic markers identified?\",\"answer\":\"Molecular subtypes were formed from TCGA gene expression data using ConsensusClusterPlus. Prognostic markers were selected using LASSO regression, followed by gene set enrichment analysis to infer potential mechanisms.\"},{\"question\":\"What genes are included in the final seven-gene signature and how was it validated?\",\"answer\":\"The signature includes GALP, CACNA1C, COL16A1, PENK, C4BPA, PSMA2, and CXCL9. Validation used robustness testing across cohorts, multivariate Cox analysis for clinical independence, nomogram assessment, and immunohistochemistry to confirm increased expression in cancer tissues.\"}]","Development and clinical validation of a seven-gene signature based on tumor stem cell-related genes to predict ovarian cancer prognosis | PDF",1790013285]